Tate & Lyle Acquired by Ingredion in £2.7 Billion Deal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 08 2026
0mins
Source: NASDAQ.COM
- Acquisition Agreement: Tate & Lyle has reached an all-cash acquisition agreement with Ingredion at 595 pence per share, valuing the deal at approximately £2.7 billion ($3.6 billion), significantly enhancing Ingredion's position in the specialty ingredients market.
- Shareholder Gains: The transaction offers Tate & Lyle shareholders a 59% premium, with completion expected in the second half of 2027, further strengthening the company's competitiveness in the health food sector.
- Cost Savings Outlook: The acquisition is projected to deliver annual run-rate cost savings of $130 million by 2030, despite initial costs of about $175 million to achieve these savings, indicating long-term financial benefits.
- Clear Financing Structure: Ingredion plans to fund the deal through cash, new debt, and, if necessary, a bridge facility, expecting a net leverage ratio of 3.0 times at closing and aiming to reduce it to 2.5 times within 18 months, demonstrating financial robustness.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INGR
Wall Street analysts forecast INGR stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 99.290
Low
119.00
Averages
125.50
High
136.00
Current: 99.290
Low
119.00
Averages
125.50
High
136.00
About INGR
Ingredion Incorporated is a global ingredient solutions provider that transforms grains, fruits, vegetables and other plant-based materials into ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. The Company operates through three segments, which include Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients (F&II)–Latin America (LATAM), and F&II–U.S./Canada. The Texture & Healthful Solutions segment primarily manufactures texturizing food ingredients. The Food & Industrial Ingredients segment primarily manufactures food, ingredient, and industrial products, which are processed from raw materials that primarily source within South America and Mexico. The Food & Industrial Ingredients–United States/Canada segment primarily manufactures food, ingredients, and industrial products. The Company's Benicaros is a patented, prebiotic fiber made from upcycled carrot pomace clinically to support immune health.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ingredion Sells Stake in Rafhan Maize for $165M
- Transaction Completion: Ingredion has finalized the sale of its 51% stake in Pakistan's Rafhan Maize for approximately $165 million, a move aimed at reducing earnings volatility and freeing up capital for investment in higher-growth businesses.
- Ownership Status: Following the transaction, Ingredion retains about a 20% ownership interest in Rafhan Maize, which generated approximately $250 million in net sales in 2025, indicating its ongoing market presence.
- Strategic Intent: This stake sale is part of Ingredion's strategy to reduce reliance on lower-growth businesses, allowing the company to focus resources on higher-potential growth areas, thereby enhancing overall financial performance.
- Market Reaction: While the transaction is expected to improve financial stability, market sentiment regarding Ingredion's long-term growth potential remains cautious, particularly in the context of its acquisition plans involving Tate & Lyle.
See More
Ingredion's $3.6 Billion Acquisition of Tate & Lyle Sparks Interest
- Acquisition Announcement: Ingredion has announced its acquisition of British ingredients company Tate & Lyle for approximately $3.6 billion in cash, significantly enhancing its market position in the food and beverage sector and creating a powerhouse in the industry.
- Market Reaction: Despite the market's muted response to this acquisition news, with Ingredion's stock down 10% year-to-date, analysts believe this deal will provide strong momentum for the company's future growth.
- Company Background: Ingredion specializes in refining corn and other starch ingredients into sweeteners, starches, and biomaterial solutions, possessing strong industry consolidation capabilities that can enhance the diversity of its product offerings.
- Investment Outlook: Although Ingredion's market capitalization stands at $6.2 billion, the scale of the Tate & Lyle acquisition is substantial, and analysts believe this will bring long-term value growth potential for investors.
See More
U.S. Stock Futures Rise as Market Sentiment Recovers
- Market Sentiment Recovery: After a significant drop on Friday, U.S. stock futures rose on Monday, with the S&P 500 gaining 0.30% despite the Dow Jones Industrial Average closing down 0.17%, indicating a slight improvement in investor sentiment.
- Rising Interest Rates Impact: The S&P 500 opened with its largest gap in eight weeks, but the rise in long-term Treasury yields, with the 30-year bond closing at 5.04%, weakened market support, preventing bulls from maintaining their initial gains.
- Oil Price Volatility: Global oil inventories continue to decline despite ceasefire efforts, with Brent crude closing at $94.22, up 1.21%, reflecting market expectations for rising oil prices that could influence investment decisions in related sectors.
- Cryptocurrency Market Recovery: Bitcoin rebounded to nearly $64,200 after shedding approximately $235 billion in market value, indicating market stabilization, although investor sentiment remains cautious, which may affect future investment flows.
See More
Tate & Lyle Acquired by Ingredion in £2.7 Billion Deal
- Acquisition Agreement: Tate & Lyle has reached an all-cash acquisition agreement with Ingredion at 595 pence per share, valuing the deal at approximately £2.7 billion ($3.6 billion), significantly enhancing Ingredion's position in the specialty ingredients market.
- Shareholder Gains: The transaction offers Tate & Lyle shareholders a 59% premium, with completion expected in the second half of 2027, further strengthening the company's competitiveness in the health food sector.
- Cost Savings Outlook: The acquisition is projected to deliver annual run-rate cost savings of $130 million by 2030, despite initial costs of about $175 million to achieve these savings, indicating long-term financial benefits.
- Clear Financing Structure: Ingredion plans to fund the deal through cash, new debt, and, if necessary, a bridge facility, expecting a net leverage ratio of 3.0 times at closing and aiming to reduce it to 2.5 times within 18 months, demonstrating financial robustness.
See More
Ingredion Acquires Tate & Lyle for £3.7 Billion
- Acquisition Overview: Ingredion Inc. announced an all-cash acquisition of British sweetener firm Tate & Lyle for £3.7 billion (approximately $5 billion), with a per-share price of 595 pence representing a 59% premium over its closing price on May 13.
- Positive Market Reaction: Shares of Tate & Lyle surged 13.25% on the London Stock Exchange to 556.50 pence, while Ingredion's shares rose 1.95% in pre-market trading on the NYSE to $101.93, indicating strong market confidence in the acquisition.
- Cost Savings Expectations: Ingredion anticipates achieving annual run-rate cost savings of $130 million by 2030, despite one-time costs of approximately $175 million to realize these savings, reflecting the company's confidence in operational efficiencies post-acquisition.
- Financial Arrangements and Outlook: The acquisition will be executed through a UK court-sanctioned scheme and is expected to close in the second half of 2027; Ingredion plans to reduce its net debt to adjusted EBITDA ratio from 3.0 to 2.5 post-transaction, demonstrating a commitment to financial stability.
See More
Tate & Lyle Agrees to £2.7 Billion Takeover by Ingredion
- Acquisition Agreement: Tate & Lyle has agreed to a £2.7 billion cash takeover by U.S.-based Ingredion, marking a significant new chapter for one of Britain's oldest industrial names and expected to enhance its position in the global food and beverage ingredients market.
- Historical Overview: Founded in the mid-19th century, Tate & Lyle has evolved from a sugar refining business to a focused food ingredients company through strategic acquisitions and restructuring, demonstrating its adaptability to market changes.
- Market Impact Analysis: This acquisition is poised to significantly increase Ingredion's market share in the global food ingredients sector, enhancing its competitiveness in the rapidly growing market for plant-based products and driving future revenue growth.
- Future Development Outlook: Upon completion of the acquisition, Tate & Lyle will leverage Ingredion's resources and network to accelerate innovation and development in health-focused foods and alternative sweeteners, aligning with current consumer trends towards healthier eating.
See More
Ingredion Sells Stake in Rafhan Maize for $165M
- Transaction Completion: Ingredion has finalized the sale of its 51% stake in Pakistan's Rafhan Maize for approximately $165 million, a move aimed at reducing earnings volatility and freeing up capital for investment in higher-growth businesses.
- Ownership Status: Following the transaction, Ingredion retains about a 20% ownership interest in Rafhan Maize, which generated approximately $250 million in net sales in 2025, indicating its ongoing market presence.
- Strategic Intent: This stake sale is part of Ingredion's strategy to reduce reliance on lower-growth businesses, allowing the company to focus resources on higher-potential growth areas, thereby enhancing overall financial performance.
- Market Reaction: While the transaction is expected to improve financial stability, market sentiment regarding Ingredion's long-term growth potential remains cautious, particularly in the context of its acquisition plans involving Tate & Lyle.
See More
Ingredion's $3.6 Billion Acquisition of Tate & Lyle Sparks Interest
- Acquisition Announcement: Ingredion has announced its acquisition of British ingredients company Tate & Lyle for approximately $3.6 billion in cash, significantly enhancing its market position in the food and beverage sector and creating a powerhouse in the industry.
- Market Reaction: Despite the market's muted response to this acquisition news, with Ingredion's stock down 10% year-to-date, analysts believe this deal will provide strong momentum for the company's future growth.
- Company Background: Ingredion specializes in refining corn and other starch ingredients into sweeteners, starches, and biomaterial solutions, possessing strong industry consolidation capabilities that can enhance the diversity of its product offerings.
- Investment Outlook: Although Ingredion's market capitalization stands at $6.2 billion, the scale of the Tate & Lyle acquisition is substantial, and analysts believe this will bring long-term value growth potential for investors.
See More
U.S. Stock Futures Rise as Market Sentiment Recovers
- Market Sentiment Recovery: After a significant drop on Friday, U.S. stock futures rose on Monday, with the S&P 500 gaining 0.30% despite the Dow Jones Industrial Average closing down 0.17%, indicating a slight improvement in investor sentiment.
- Rising Interest Rates Impact: The S&P 500 opened with its largest gap in eight weeks, but the rise in long-term Treasury yields, with the 30-year bond closing at 5.04%, weakened market support, preventing bulls from maintaining their initial gains.
- Oil Price Volatility: Global oil inventories continue to decline despite ceasefire efforts, with Brent crude closing at $94.22, up 1.21%, reflecting market expectations for rising oil prices that could influence investment decisions in related sectors.
- Cryptocurrency Market Recovery: Bitcoin rebounded to nearly $64,200 after shedding approximately $235 billion in market value, indicating market stabilization, although investor sentiment remains cautious, which may affect future investment flows.
See More
Tate & Lyle Acquired by Ingredion in £2.7 Billion Deal
- Acquisition Agreement: Tate & Lyle has reached an all-cash acquisition agreement with Ingredion at 595 pence per share, valuing the deal at approximately £2.7 billion ($3.6 billion), significantly enhancing Ingredion's position in the specialty ingredients market.
- Shareholder Gains: The transaction offers Tate & Lyle shareholders a 59% premium, with completion expected in the second half of 2027, further strengthening the company's competitiveness in the health food sector.
- Cost Savings Outlook: The acquisition is projected to deliver annual run-rate cost savings of $130 million by 2030, despite initial costs of about $175 million to achieve these savings, indicating long-term financial benefits.
- Clear Financing Structure: Ingredion plans to fund the deal through cash, new debt, and, if necessary, a bridge facility, expecting a net leverage ratio of 3.0 times at closing and aiming to reduce it to 2.5 times within 18 months, demonstrating financial robustness.
See More
Ingredion Acquires Tate & Lyle for £3.7 Billion
- Acquisition Overview: Ingredion Inc. announced an all-cash acquisition of British sweetener firm Tate & Lyle for £3.7 billion (approximately $5 billion), with a per-share price of 595 pence representing a 59% premium over its closing price on May 13.
- Positive Market Reaction: Shares of Tate & Lyle surged 13.25% on the London Stock Exchange to 556.50 pence, while Ingredion's shares rose 1.95% in pre-market trading on the NYSE to $101.93, indicating strong market confidence in the acquisition.
- Cost Savings Expectations: Ingredion anticipates achieving annual run-rate cost savings of $130 million by 2030, despite one-time costs of approximately $175 million to realize these savings, reflecting the company's confidence in operational efficiencies post-acquisition.
- Financial Arrangements and Outlook: The acquisition will be executed through a UK court-sanctioned scheme and is expected to close in the second half of 2027; Ingredion plans to reduce its net debt to adjusted EBITDA ratio from 3.0 to 2.5 post-transaction, demonstrating a commitment to financial stability.
See More
Tate & Lyle Agrees to £2.7 Billion Takeover by Ingredion
- Acquisition Agreement: Tate & Lyle has agreed to a £2.7 billion cash takeover by U.S.-based Ingredion, marking a significant new chapter for one of Britain's oldest industrial names and expected to enhance its position in the global food and beverage ingredients market.
- Historical Overview: Founded in the mid-19th century, Tate & Lyle has evolved from a sugar refining business to a focused food ingredients company through strategic acquisitions and restructuring, demonstrating its adaptability to market changes.
- Market Impact Analysis: This acquisition is poised to significantly increase Ingredion's market share in the global food ingredients sector, enhancing its competitiveness in the rapidly growing market for plant-based products and driving future revenue growth.
- Future Development Outlook: Upon completion of the acquisition, Tate & Lyle will leverage Ingredion's resources and network to accelerate innovation and development in health-focused foods and alternative sweeteners, aligning with current consumer trends towards healthier eating.
See More
